Bildkälla: Stockfoto

Alzecure: Receives Approval to Start ACD856 Phase I “MAD” Study - Redeye

We give a brief comment on today's news that Alzecure has recieved approval to start the "MAD"-part of its phase 1 study for ACD856.

We give a brief comment on today's news that Alzecure has recieved approval to start the "MAD"-part of its phase 1 study for ACD856.
Börsvärldens nyhetsbrev
ANNONSER